Fig. 2From: Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort studyPropensity-score-weighted hazard ratios for CV events during as-treated follow-up period: Primary comparison. ATV, atazanavir; CABG, coronary artery bypass graft; CI, confidence interval; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary interventionBack to article page